Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GARIN3 pseudogene 1 (GARIN3P1, also known as FAM71BP1) is annotated as a *pseudogene*, meaning it is a sequence in the human genome that resembles a protein-coding gene but generally contains mutations or deletions that prevent its translation into a functional protein[1]. It is located on chromosome 9 and is a member of the FAM71B pseudogene family. While some pseudogenes have been implicated in gene regulation through their RNA products—such as acting as competing endogenous RNAs, microRNA decoys, or regulatory elements affecting parental gene expression—there are no functionally characterized or disease associations reported for GARIN3P1 itself in the available literature[1][2]. It is not currently considered a therapeutic target, nor is it assigned a role in disease, drug interaction, gene expression regulation, or as a biomarker. Key points: - GARIN3P1 is a pseudogene with no evidence of coding or functional protein expression[1]. - Pseudogenes in general can sometimes have RNA-mediated regulatory effects, but specific evidence for GARIN3P1 is lacking in current databases and publications[2]. - It should not be used as a model drug target or assigned mechanisms of action, interacting drugs, biomarker status, or safety concerns in therapeutic contexts. If a regulatory or other function for GARIN3P1 is discovered in future genomics research, these attributes could be updated, but as of now it remains a non-target pseudogene[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GARIN3 pseudogene 1 (GARIN3P1).